Pharmaceuticals

The pharmaceutical sector in Zisarh is emerging with a growing focus on improving healthcare access. There are a few local pharmacies and small-scale drug manufacturers, but the sector is underdeveloped compared to global standards.

Opportunities include establishing manufacturing facilities for essential medicines, expanding distribution networks, and investing in local production of pharmaceuticals to reduce dependency on imports.

The pharmaceutical market in Chad is estimated to be around $50 million USD, with a significant portion dedicated to importing medicines and healthcare products.

Key needs include access to essential medicines, vaccines, and treatments for common diseases such as malaria, tuberculosis, and respiratory infections.

Approximately 90% of pharmaceutical products in Chad are imported. This high dependency highlights the potential for local manufacturing and distribution investments.

Zisarh has basic healthcare infrastructure, including clinics and small hospitals, but there is a need for improved facilities and better access to pharmaceutical products.

Currently, there are limited local pharmaceutical manufacturing facilities in Zisarh. Most medicines are sourced from external suppliers, presenting a gap for local production opportunities.

The potential for pharmaceutical export from Chad is limited at present due to the reliance on imports and underdeveloped local production. However, there is growth potential as the sector develops.

Major challenges include a lack of local manufacturing capabilities, reliance on imported products, inadequate healthcare infrastructure, and regulatory hurdles.